IMPORTANT UPDATES

Child getting a covid-19 test

COVID-19 Research

From the moment COVID-19 began, Children’s and Emory researchers applied their vast array of knowledge and expertise to meet it head on.

See all research

Changing the Course of a Pandemic

The work of researchers at Children’s and Emory has helped change the course of the COVID-19 pandemic. We were on the forefront of COVID-19 research that allowed for the gradual return to everyday life by leading to authorization of pediatric vaccines, availability of at-home tests, authorization of new drugs for treatment, assessing antibodies and variants, and identification of potential biomarkers. These discoveries have helped. Kids are back in the classroom and participating in social activities in person once again—and it was all made possible, in part, by discoveries made in our labs and clinics.

  • Children's tests COVID-19 diagnostic tests for the NIH

    Children’s, Emory University and Georgia Tech were selected to verify COVID-19 diagnostic tests from across the nation that were submitted for the RADx Program through the National Institutes of Health (NIH).

  • COVID-19 Biomarker Discovery

    No reliable biomarker for predicting COVID-19 and MIS-C severity was available until a serendipitous discovery was made by the Children’s Pediatric Neurotrauma Lab.

  • Now playing

    Children's tests COVID-19 diagnostic tests for the NIH

  • Now playing

    COVID-19 Biomarker Discovery

Paxlovid trial child with nurse

8/9/22

Testing a Pill to Treat Kids at High Risk for Severe COVID-19

Children’s and Emory are participating in a global trial testing the Pfizer oral anti-viral medication, Paxlovid, in children under age 18.
Researchers in lab

9/27/21

Children's Study Shows Evidence of COVID-19 and MIS-C Biomarker

Increased levels of plasma osteopontin were observed in patients with COVID-19 and multi-system inflammatory condition in children (MIS-C).
building

5/10/21

Children’s and Emory Launch Moderna COVID-19 Vaccine Trial

The trial will test the Moderna COVID-19 vaccine in children ages 6 months to less than 12 years.
Dr. Wilbur Lam researching COVID-19 diagnostic tests

10/5/20

54 Million Total Awarded From NIH for COVID-19 Testing

Children’s, with its partners Emory University and Georgia Tech, has been awarded a total of $54 million from NIH to evaluate COVID-19 diagnostic testing.

Recent Publications: See How Our COVID-19 Research Is Making an Impact

2021 Research Report

Unprecedented Discoveries, Global Impact

Researchers at Children’s and Emory have shown what it takes to combat a pandemic. Unprecedented discoveries in COVID-19 have had a global impact while our standard research program has continued to achieve significant milestones, including a $31 million grant for the Marcus Center for Pediatric Cellular Therapies.

Read Our Research Report
Get the Latest News

Receive our latest research and innovation updates straight to your inbox.

Research into COVID-19 is ongoing, with new discoveries coming at an unprecedented pace. To stay on top of research advancements at Children’s, sign up for our updates.

SUBSCRIBE

Contact Us 404-785-KIDS (5437)